Lenvatinib Shows Promising Results In Halting The Progression Of Thyroid Cancer A new drug developed by Japanese pharmaceutical firm Eisai shows almost five-fold improvement in the progression-free survival of thyroid cancer patients. However, it is not without risks. by Nicole Arce